Attached files

file filename
8-K - 8-K - SPARTON CORPq1fy2018earningsrelease-8k.htm


 
 
Media Contact:
 
Joe McCormack
 
 
 
 
Sparton Corporation
 
 
 
 
Email: ir@sparton.com
 
 
 
 
Office: (847) 762-5800
FOR IMMEDIATE RELEASE
Sparton Corporation Reports Fiscal 2018 First Quarter Results
SCHAUMBURG, IL. - November 9, 2017 - Sparton Corporation (NYSE: SPA) today announced results for the first quarter of fiscal year 2018 ended October 1, 2017.
First Quarter Financial Results and Highlights
Joseph J. Hartnett, Interim President & CEO, commented, “As a result of our recent growth in new program wins, we experienced some interruptions in production and increased inventory levels which is typical with new program introductions. We believe that the backlog from these programs has us positioned for growth in the upcoming quarters and beyond.”
Joseph G. McCormack, Senior Vice President & CFO, commented, “We experienced net cash outflows and increasing debt in the quarter. This was principally the result of the timing of a payment from the U.S. Navy, significant transaction-related costs as a result of the signing of the merger agreement during the quarter, increasing inventories as a result of the new product introductions, as well as typical year-end compensation related payments. The underlying fundamentals of the business remain unchanged and we expect to return to positive free cash flows and reducing our debt levels in the second quarter.”
Consolidated:
• Net sales of $82.8 million
• Gross profit margin of 17.6%
• SG&A expenses of $15.2 million or 18.4% of sales; adjusted SG&A of $12.9 million, 15.5% of sales
• Loss per share of $0.29, adjusted earnings per share of $0.00
• Adjusted EBITDA of $2.9 million, a 3.5% adjusted EBITDA margin
MDS Segment:
• Gross sales of $55.3 million
• Gross profit margin of 10.8%
• Operating loss of $1.5 million
• Adjusted EBITDA of $3.3 million, a 1.5% adjusted EBITDA margin
• New program wins in Q4 have expected revenue of $11.7 million when fully ramped up into production
• Trailing four quarter new program win revenue of $61.9 million, which continues to support our future organic growth
ECP Segment:
• Gross sales of $30.4 million
• Gross profit margin of 28.3%
• Operating income of $4.1 million
• Adjusted EBITDA of $5.7 million, a 15.4% adjusted EBITDA margin

SELECTED FINANCIAL DATA
 
For the Quarters Ended
 
Q1 FY18
 
Q4 FY17
 
Q1 FY17
 
(Dollars in thousands, except per share data)
Consolidated:
 
 
 
 
 
Net sales
$
82,763

 
$
104,386

 
$
100,367

Gross profit
14,588

 
21,801

 
17,285

Selling and administrative expenses
15,205

 
14,913

 
13,383

Operating income
(3,112
)
 
4,538

 
1,332

Adjusted operating income (non-GAAP)
1,162

 
7,638

 
4,314

Earnings per share
(0.29
)
 
0.17

 
0.01

Adjusted Earnings per share (non-GAAP)

 
0.38

 
0.20

EBITDA (non-GAAP)
337

 
7,978

 
5,071

Adjusted EBITDA (non-GAAP)
2,899

 
9,727

 
6,143

Adjusted EBITDA margin (non-GAAP)
3.5
%
 
9.3
%
 
6.1
%
Free cash flow (non-GAAP)
$
(23,684
)
 
$
13,895

 
$
2,093

 
 
 
 
 
 
MDS Segment:
 
 
 
 
 
Gross sales
$
55,308

 
$
67,046

 
$
65,002

Intercompany sales
(2,937
)
 
(2,887
)
 
(2,200
)
Net sales
52,371

 
64,159

 
62,802

Gross profit
5,993

 
9,100

 
7,294

Selling and administrative expenses
3,454

 
3,446

 
3,508

Allocation of corporate expenses
2,446

 
2,456

 
2,468

Operating Income (loss)
(1,485
)
 
1,557

 
(514
)
Adjusted Segment EBITDA (non-GAAP)
$
3,250

 
$
6,428

 
4,691

 
 
 
 
 
 
ECP Segment:
 
 
 
 
 
Gross sales
$
30,399

 
$
40,264

 
$
37,592

Intercompany sales
(7
)
 
(37
)
 
(27
)
Net sales
30,392

 
40,227

 
37,565

Gross profit
8,595

 
12,701

 
9,991

Selling and administrative expenses
2,589

 
2,709

 
2,624

Allocation of corporate expenses
991

 
1,470

 
1,200

Operating Income
4,098

 
7,813

 
5,429

Adjusted Segment EBITDA (non-GAAP)
$
5,678

 
$
9,859

 
7,228

Liquidity and Capital Resources
As of October 1, 2017, the Company had $22 million available under its $125 million credit facility.
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (“GAAP”), Sparton Corporation has provided certain non-GAAP financial measures as additional information for its operating results. These measures have not been prepared in accordance with GAAP and may be different from measures used by other companies. Whenever we use non-GAAP financial measures, we designate these measures, which exclude the effects of certain expenses and income, as “adjusted” and provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. The non-GAAP financial measures eliminate or add certain items of expense and income from total operating expense and income taxes. Management believes that this presentation is helpful to investors in evaluating the current operational and financial performance of our business and facilitates comparisons to historical results of operations. Management discloses this information along with a reconciliation of the comparable GAAP amounts to provide access to the detail and nature of adjustments made to GAAP financial results. While some of these excluded items have been periodically reported in our statements of operations, their occurrence in future periods depends on future business and economic factors, among other evaluation criteria, and the occurrence of such events and factors may frequently be beyond the control of management.
When we calculate adjusted earnings per share, adjusted EBITDA and other adjustments to the statements of income, we exclude certain expenses and income because we believe that they are not related directly to the underlying performance of our fundamental business operations. We exclude these measures when reviewing financial results and for business planning. Although these events are reflected in our GAAP financial statements, these transactions may limit the comparability of our fundamental operations with prior and future periods. We believe EBITDA and adjusted EBITDA are commonly used by financial analysts and others in the industries in which the Company operates and, thus, provides useful information to investors. The Company does not intend, nor should the reader consider, EBITDA or adjusted EBITDA to be an alternative to operating income, net income, net cash provided by operating activities or any other items calculated in accordance with GAAP. The Company's definition of adjusted EBITDA may not be comparable with other companies. Accordingly, the measurement has limitations depending on its use.
About Sparton Corporation
Sparton Corporation (NYSE:SPA), now in its 118th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, field service and refurbishment. The primary markets served are Medical & Biotechnology, Military & Aerospace and Industrial & Commercial. Headquartered in Schaumburg, IL, Sparton currently has thirteen manufacturing locations and engineering design centers worldwide. Sparton's Web site may be accessed at www.sparton.com.
Safe Harbor and Fair Disclosure Statement
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in Sparton’s filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton’s services described in Sparton’s filings with the SEC. In particular, see the risk factors described in Sparton’s most recent Form 10-K and Form 10-Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.

1



CONSOLIDATING FINANCIAL INFORMATION - Q1 FISCAL YEAR 2018
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
52,371

 
$
30,392

 
$
82,763

Cost of goods sold

 
46,378

 
21,797

 
68,175

Gross profit

 
5,993

 
8,595

 
$
14,588

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
9,162

 
3,454

 
2,589

 
15,205

Selling and administrative - Corp allocations
(3,437
)
 
2,446

 
991

 

Internal research and development

 

 
572

 
572

Amortization of intangible assets

 
1,578

 
345

 
1,923

Total operating expenses
5,725

 
7,478

 
4,497

 
17,700

Income (loss) from operations
(5,725
)
 
(1,485
)
 
4,098

 
(3,112
)
Interest expense, net
(1,266
)
 

 

 
(1,266
)
Other income (expense)

 
(38
)
 
28

 
(10
)
Income taxes
1,536

 

 

 
1,536

Net income (loss)
$
(5,455
)
 
$
(1,523
)
 
$
4,126

 
$
(2,852
)
Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
(0.29
)
Diluted
 
 
 
 
 
 
(0.29
)
Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,834,723

Diluted
 
 
 
 
 
 
9,834,723


CONSOLIDATING FINANCIAL INFORMATION - Q1 FISCAL YEAR 2017
(Dollars in thousands, except per share data)
 
Corporate
 
MDS
 
ECP
 
Total
Net Sales
$

 
$
62,802

 
$
37,565

 
$
100,367

Cost of goods sold

 
55,508

 
27,574

 
83,082

Gross profit

 
7,294

 
9,991

 
$
17,285

Operating expenses:
 
 
 
 
 
 
 
Selling and administrative
7,251

 
3,508

 
2,624

 
13,383

Selling and administrative - Corp allocations
(3,668
)
 
2,468

 
1,200

 

Internal research and development

 

 
351

 
351

Amortization of intangible assets

 
1,832

 
387

 
2,219

Total operating expenses
3,583

 
7,808

 
4,562

 
15,953

Income (loss) from operations
(3,583
)
 
(514
)
 
5,429

 
1,332

Interest expense, net
(1,186
)
 
1

 

 
(1,185
)
Other income (expense)
(1
)
 
29

 
(8
)
 
20

Income taxes
(63
)
 

 
4

 
(59
)
Net income (loss)
$
(4,833
)
 
$
(484
)
 
$
5,425

 
$
108

Income per share of common stock:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
$
0.01

Diluted
 
 
 
 
 
 
0.01

Weighted average shares of common stock outstanding:
 
 
 
 
 
 
 
Basic
 
 
 
 
 
 
9,792,818

Diluted
 
 
 
 
 
 
9,792,818


2



CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

 
For the Fiscal Years
 
2018
 
2017
 
($ in thousands)
Cash Flows from Operating Activities:
 
 
 
Operating activities, net of working capital changes
$
1,049

 
$
4,279

Net changes in working capital
(24,278
)
 
(1,067
)
Cash Flows from Operating Activities
(23,229
)
 
3,212

Cash Flows from Investing Activities:
 
 
 
Capital expenditures
(455
)
 
(1,119
)
Cash Flows from Investing Activities
(455
)
 
(1,119
)
Cash Flows from Financing Activities:
 
 
 
Net change in credit facility
23,100

 
(1,431
)
Other financing activities
(85
)
 
(76
)
Cash Flows from Financing Activities
23,015

 
(1,507
)
Change in Cash and Cash Equivalents
(669
)
 
586

 
 
 
 
Cash and Cash Equivalents - Beginning
988

 
132

Cash and Cash Equivalents - Ending
$
319

 
$
718



CONDENSED CONSOLIDATED BALANCE SHEETS
 
October 1,
2017
 
July 2,
2017
 
($ in thousands)
Assets
 
 
 
Cash and cash equivalents
$
319

 
$
988

Accounts receivable, net
53,933

 
45,347

Inventories
68,646

 
60,248

Prepaid and other current assets
4,443

 
3,851

Property, plant and equipment, net
33,374

 
34,455

Goodwill
12,663

 
12,663

Other intangible assets, net
26,522

 
28,445

Other assets
30,544

 
31,146

Total assets
$
230,444

 
$
217,143

Liabilities and Shareholders’ Equity
 
 
 
Accounts payable
$
30,278

 
$
27,672

Accrued expenses
17,030

 
26,580

Credit facility
97,600

 
74,500

Capital lease obligations, long term
100

 
167

Environmental
5,322

 
5,468

Pension
851

 
888

Shareholders’ Equity
79,263

 
81,868

Total Liabilities and Shareholders’ Equity
$
230,444

 
$
217,143


3



RECONCILIATION OF NON-GAAP MEASURES

EBITDA Reconciliation (Non-GAAP) - Q1 Fiscal Year 2018
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(5,455
)
 
$
(1,523
)
 
$
4,126

 
$
(2,852
)
Interest expense, net
1,266

 

 

 
1,266

Income taxes
(1,536
)
 

 

 
(1,536
)
Amortization of intangible assets

 
1,578

 
345

 
1,923

Depreciation
571

 
749

 
216

 
1,536

Selling and administrative - Corp allocations
(3,437
)
 
2,446

 
991

 

EBITDA, excluding corporate allocation
(8,591
)
 
3,250

 
5,678

 
337

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Stock-based compensation
211

 

 

 
211

Costs related to potential sale of Company
2,351

 

 

 
2,351

Adjusted EBITDA, before corporate allocation
$
(6,029
)
 
$
3,250

 
$
5,678

 
$
2,899

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(2,592
)
 
$
804

 
$
4,687

 
$
2,899

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
3.5
%

EBITDA Reconciliation (Non-GAAP) - Q1 Fiscal Year 2017
(Dollars in thousands)
 
Corporate
 
MDS
 
ECP
 
Total
Net income (loss)
$
(4,833
)
 
$
(484
)
 
$
5,425

 
$
108

Interest expense, net
1,186

 
(1
)
 

 
1,185

Income taxes
63

 

 
(4
)
 
59

Amortization of intangible assets

 
1,832

 
387

 
2,219

Depreciation included in SG&A above
438

 
842

 
220

 
1,500

Selling and administrative - Corp allocations
(3,668
)
 
2,468

 
1,200

 

EBITDA, excluding corporate allocation
(6,814
)
 
4,657

 
7,228

 
5,071

Adjustments for nonrecurring operating expenses:
 
 
 
 
 
 
 
Stock-based compensation
309

 

 

 
309

Costs related to potential sale of company
629

 
34

 

 
663

Other non-recurring costs
100

 

 

 
100

Adjusted EBITDA, before corporate allocation
$
(5,776
)
 
$
4,691

 
$
7,228

 
$
6,143

 
 
 
 
 
 
 
 
Adjusted EBITDA, after corporate allocation
$
(2,108
)
 
$
2,223

 
$
6,028

 
$
6,143

 
 
 
 
 
 
 
 
Adjusted EBITDA margin
 
 
 
 
 
 
6.1
%


4



Adjusted EPS (Non-GAAP)
 
For the Quarters Ended
 
Q1 FY18
 
Q4 FY17
 
Q1 FY17
 
(Dollars in thousands, except per share data)
Earnings per share - diluted, as reported
$
(0.29
)
 
$
0.17

 
$
0.01

Nonrecurring items
0.16

 
0.08

 
0.05

Amortization of intangible assets
0.13

 
0.13

 
0.14

Adjusted earnings per share
$

 
$
0.38

 
$
0.20

 
 
 
 
 
 
Adjustments, net of tax:
 
 
 
 
 
Costs related to potential sale of Company
$
1,528

 
$
722

 
$
431

Total nonrecurring
1,528

 
722

 
496

Amortization of intangible assets
1,250

 
1,293

 
1,442

Total adjustments
$
2,778

 
$
2,015

 
$
1,938



5



Adjusted SG&A and Operating Income (Non-GAAP)
 
For the First Quarters Ended
 
Q1 FY18
 
Q4 FY17
 
Q1 FY17
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
SG&A
 
Operating Income
 
(Dollars in thousands)
As reported
$
15,205

 
$
(3,112
)
 
$
14,913

 
$
4,538

 
$
13,383

 
$
1,332

Percentage of sales
18.4
%
 
(3.8
)%
 
14.3
%
 
4.3
%
 
13.3
%
 
1.3
%
Adjustments:
 
 
 
 
 
 
 
 
 
 
 
Amortization of intangible assets

 
1,923

 

 
1,989

 

 
2,219

Costs related to potential sale of Company
2,351

 
2,351

 
1,111

 
1,111

 
663

 
663

Other nonrecurring adjustments

 

 

 

 
100

 
100

     Total adjustments
2,351

 
4,274

 
1,111

 
3,100

 
763

 
2,982

As adjusted
$
12,854

 
$
1,162

 
$
13,802

 
$
7,638

 
$
12,620

 
$
4,314

 
 
 
 
 
 
 
 
 
 
 
 
Adjusted percentage of sales
15.5
%
 
1.4
 %
 
13.2
%
 
7.3
%
 
12.6
%
 
4.3
%




6